AAPPTec Custom Peptides in the Literature
AAPPTec provides high quality custom peptides to researchers around the world. Below are a few examples of recent papers where AAPPTec custom peptides were utilized. Click on the title to go to the paper or abstract.
“Elucidation of Aggregation Pathways of Helix-Turn-Helix Peptides: Stabilization at the Turn Region Is Critical for Fibril Formation”, Do, TD; Chamas, A; Zheng, X; Barnes, A; Chang, D; Veldstra, T; Takhar, H; Dressler, N; Trapp, B; Miller, K; McMahon, A; Meredith, SC; Shea, J-E; Cantrell, KL; Bowers, MT., Biochemistry, 2015, 54, 4050-62.
“Defining Species-Specific Immunodominant B Cell Epitopes for Molecular Serology of Chlamydia Species”, Rahman, KS; Chowdhury, EU; Poudel, A; Ruettger, A; Sachse, K; Kaltenboeck, B., Clin. Vaccine Immunol., 2015, 22, 539-52.
“Keratin 1 Plays a Critical Role in Golgi Localization of Core 2 N-Acetylglucosaminyltransferase M via Interaction with Its Cytoplasmic Tail”, Petrosyan, A; Ali, MF; Cheng, P-W., J. Biol. Chem., 2015, 290, 6256-6269.
“CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppresion and Targeting Cancer-Initiating Cells“, Gil, M; Komorowski, MP; Seshadri, M; Rokita, H; McGray, AJR; Opyrchal, M; Odunsi, KO; Kozbor, D., J. Immunol., 2014, 193, 5327-5337.
“Gamma-Secretase Processing and Effects of gamma-Secretase Inhibitors and Modulators on Long Aβ Peptides in Cells”, Ran, Y; Cruz, PE; Ladd, TB; Fauq, AH; Jung, JI; Matthews, J; Felsenstein, KM; Golde, TE., J. Biol. Chem., 2014, 289, 3276-3287. DOI: 10.1074/jbc.M113.512921
“Mechanism of ubiquitin ligation and lysine prioritization by a HECT E3”, Kamadurai, HB; Qiu, Y; Deng, A; Harrison, JS; MacDonald, C; Actis, M; Rodrigues, P; Miller, DJ; Souphron, J; Lewis, SM; Kurinov, I; Fujii, N; Hammel, M; Piper, R; Kuhlman, B; Schulman, BA., eLife Sci, Aug 2013; 2, e00828. DOI: 10.7554/eLife.00828
“Role of Aldose Reductase in the Metabolism and Detoxification of Carnosine-Acrolein Conjugates”, Baba, SP; Hoetker, JD; Merchant, M; Klein, JB; Cai, J; Barski, OA; Conklin, DJ; Bhatnagar, A., J. Biol. Chem., 2013; 288, 28163 – 28179. DOI: 10.1074/jbc.M113.504753
“Chemokine CXCL1 Dimer Is a Potent Agonist for the CXCR2 Receptor”, Ravindran, A; Sawant, KV; Sarmiento, J; Navarro, J; Rajarathnam, K., J. Biol. Chem., 2013, 288, 12244 – 12252. DOI:10.1074/jbc.M112.443762
“Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases”, Gil, M; Seshadri, M; Komorowski, MP; Abrams, SI; Kozbor, D., Proc. Natl. Acad. Sci., 2013, 110, E1291-E1300. DOI: 10.1073/pnas.1220580110
“Spiral counter-current chromatography of small molecules, peptides and proteins using the spiral tubing support rotor”, Knight, M; Finn, TM; Zehmer, J; Clayton, A; Pilon, A., J.Chromatogr. A, 2011, 1218, 6148–6155.
“Abstract 2299: IL-8 receptor CXCR1 expressed in human breast epithelial cells MCF-10F is down regulated by human chorionic gonadotropin and its peptide 81-95”, Ribeiro de Noronha, SM; Correa-Noronha, SAA; Russo, IH; Lopez, R; Pereira, JS; Russo, J., Cancer Res., 2011, 71, 2299. DOI: 10.1158/1538-7445.AM2011-2299 DOI: 10.1016/j.chroma.2011.06.007
“Bioartificial Matrixes for Therapeutic Vascularization”, Phelps EA, Landázuri N, Thulé PM, Taylor R, García AJ., Proc. Nat. Acad. Sci. USA, 2010, 107, 3323-8. DOI: 10.1073/pnas.0905447107
“Whole Blood Assay for Elastase, Chymotrypsin, Matrix Metalloproteinase-2, and Matrix Metalloproteinase-9 Activity”, Lefkowitz, RB; Schmid-Schönbein, GW; Heller, MJ., Anal. Chem., 2010, 82, 8251-8. DOI: 10.1021/ac101462c
“Protein Modification by Acrolein: Formation and Stability of Cysteine Adducts”, Cai, J; Bhatnagar, A; Pierce, WM., Jr., Chem. Res. Toxicol., 2009, 22, 708-16. DOI: 10.1021/tx800465m
